Cargando…
Osteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in mice
AIMS/HYPOTHESIS: Obesity is strongly associated with the development of non-alcoholic fatty liver disease (NAFLD). The cytokine osteopontin (OPN) was recently shown to be involved in obesity-induced adipose tissue inflammation and reduced insulin response. Accumulating evidence links OPN to the path...
Autores principales: | Kiefer, F. W., Neschen, S., Pfau, B., Legerer, B., Neuhofer, A., Kahle, M., Hrabé de Angelis, M., Schlederer, M., Mair, M., Kenner, L., Plutzky, J., Zeyda, M., Stulnig, T. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131508/ https://www.ncbi.nlm.nih.gov/pubmed/21562757 http://dx.doi.org/10.1007/s00125-011-2170-0 |
Ejemplares similares
-
Neutralization of Osteopontin Inhibits Obesity-Induced Inflammation and Insulin Resistance
por: Kiefer, Florian W., et al.
Publicado: (2010) -
Osteopontin is a key player for local adipose tissue macrophage proliferation in obesity
por: Tardelli, Matteo, et al.
Publicado: (2016) -
Inhibition of Cellular Adhesion by Immunological Targeting of Osteopontin Neoepitopes Generated through Matrix Metalloproteinase and Thrombin Cleavage
por: Jürets, Alexander, et al.
Publicado: (2016) -
CTX (Crosslaps) Rather than Osteopontin Is Associated with Disturbed Glucose Metabolism in Gestational Diabetes
por: Winhofer, Yvonne, et al.
Publicado: (2012) -
Impact of osteopontin on the development of non‐alcoholic liver disease and related hepatocellular carcinoma
por: Nardo, Alexander D., et al.
Publicado: (2020)